Literature DB >> 11406088

Should patients with asymptomatic wolff-parkinson-white pattern undergo a catheter ablation?

P LeLorier1, G J Klein, A Krahn, R Yee, A Skanes .   

Abstract

Many individuals with the Wolff-Parkinson-White electrocardiographic pattern are asymptomatic. Optimal management of these individuals is still a matter of debate. On the one hand, sudden cardiac death from ventricular fibrillation is a rare yet possible outcome in these individuals. On the other hand, there is a low risk of serious complication from electrophysiologic study and ablation. Given that the risk of these competing strategies is comparable, the decision needs to be individualized with considerable patient input.

Entities:  

Mesh:

Year:  2001        PMID: 11406088     DOI: 10.1007/s11886-001-0084-z

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  22 in total

1.  Multiple accessory pathways in the Wolff-Parkinson-White syndrome as a risk factor for ventricular fibrillation.

Authors:  W S Teo; G J Klein; G M Guiraudon; R Yee; J W Leitch; D McLellan; R A Leather; Y H Kim
Journal:  Am J Cardiol       Date:  1991-04-15       Impact factor: 2.778

2.  Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test.

Authors:  H Calkins; J Sousa; R el-Atassi; S Rosenheck; M de Buitleir; W H Kou; A H Kadish; J J Langberg; F Morady
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

3.  Safety of electrophysiologic studies.

Authors:  L N Horowitz
Journal:  Circulation       Date:  1986-02       Impact factor: 29.690

4.  Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern.

Authors:  J W Leitch; G J Klein; R Yee; C Murdock
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

5.  Radiofrequency current catheter ablation of accessory atrioventricular pathways.

Authors:  K H Kuck; M Schlüter; M Geiger; J Siebels; W Duckeck
Journal:  Lancet       Date:  1991-06-29       Impact factor: 79.321

6.  Curative percutaneous catheter ablation using radiofrequency energy for accessory pathways in all locations: results in 100 consecutive patients.

Authors:  M D Lesh; G F Van Hare; D J Schamp; W Chien; M A Lee; J C Griffin; J J Langberg; T J Cohen; K G Lurie; M M Scheinman
Journal:  J Am Coll Cardiol       Date:  1992-05       Impact factor: 24.094

7.  Value of a revised procainamide test in the Wolff-Parkinson-White syndrome.

Authors:  K A Boahene; G J Klein; A D Sharma; R Yee; O Fujimura
Journal:  Am J Cardiol       Date:  1990-01-15       Impact factor: 2.778

8.  Transesophageal pacing for prognostic evaluation of preexcitation syndrome and assessment of protective therapy.

Authors:  G Critelli; G Grassi; F Perticone; F Coltorti; V Monda; M Condorelli
Journal:  Am J Cardiol       Date:  1983-02       Impact factor: 2.778

9.  Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome.

Authors:  A D Sharma; R Yee; G Guiraudon; G J Klein
Journal:  J Am Coll Cardiol       Date:  1987-08       Impact factor: 24.094

10.  Comparison of exercise and ajmaline tests with electrophysiologic study in the Wolff-Parkinson-White syndrome.

Authors:  Y Eshchar; B Belhassen; S Laniado
Journal:  Am J Cardiol       Date:  1986-04-01       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.